Collectively, these results indicate that deletion of CD38 reduces the hypertrophic response to ISO infusion and preserves cardiac function, and that cADPR-mediated Ca2+ signaling plays a critical role in ISO-induced cardiac hypertrophy and fibrosis. The gene discussed is CD38; the disease is cardiac hypertrophy.